- Update on the pathology of liver neoplasms
Karen E. Matsukuma et al, 2019, Annals of Diagnostic Pathology CrossRef - The Diagnostic Value of Arginase-1, FTCD, and MOC-31 Expression in Early Detection of Hepatocellular Carcinoma (HCC) and in Differentiation Between HCC and Metastatic Adenocarcinoma to the Liver
Osama H. Labib et al, 2020, Journal of Gastrointestinal Cancer CrossRef - Role of arginase 1 immunohistochemical marker in differentiating hepatocellular carcinoma from other primary and secondary carcinomas of the liver, a tissue microarray study
Shaimaa M Yussif et al, 2022, Indian Journal of Pathology and Oncology CrossRef - The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1
Nehal A Radwan et al, 2012, Diagnostic Pathology CrossRef - Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma
Teresa Pollicino et al, 2019, Oncotarget CrossRef - Practical Immunohistochemistry in Neoplastic Pathology of the Gastrointestinal Tract, Liver, Biliary Tract, and Pancreas
Hanlin L. Wang et al, 2017, Archives of Pathology & Laboratory Medicine CrossRef - HepPar-1 Expression in Primary Lung Adenocarcinoma
Samuel A. Yousem et al, 2013, American Journal of Clinical Pathology CrossRef - Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma
Thuy Nguyen et al, 2015, Archives of Pathology & Laboratory Medicine CrossRef - Large-Scale Tissue Microarray Evaluation Corroborates High Specificity of High-Level Arginase-1 Immunostaining for Hepatocellular Carcinoma
Maximilian Lennartz et al, 2021, Diagnostics CrossRef